Franz Schürmann, Portfolio Analysis & Reporting for Syngenta's Global R&D, discusses the challenges of Portfolio Management in the Crop Science sector, and why Planisware has become a strategic partner of Syngenta.
COVID-19 presents unprecedented challenges for the MedTech industry. Read on to discover some of the most striking R&D changes in the new MedTech market, and the strategies that will drive tomorrow’s innovation.